title: Effects on articular cartilage of subchondral replacement with polymethylmethacrylate and calcium phosphate cement.
abstract: Bone defects were created in rabbit medial femoral condyle in a model where subchondral bone was completely removed or about 2 mm of subchondral bone was maintained. Groups without augmentation and augmented with autogenous bone, polymethylmethacrylate, or calcium phosphate cement were sacrificed at 3, 12, and 24 weeks for evaluation of articular cartilage and observation of bone formation. In the model in which subchondral bone was completely removed, collapse of the subchondral bone together with exfoliation and prolapse of cartilage developed early in all cases. In the model in which 2 mm of subchondral bone was maintained, degeneration of articular cartilage developed at 12 weeks in the group augmented with polymethylmethacrylate, showing a significant difference when compared to the contralateral untreated control group. The group augmented with calcium phosphate cement did not demonstrate any evident difference from the control group. Mechanical properties after subchondral replacement did not differ between the groups augmented with polymethylmethacrylate and calcium phosphate cement, although calcium phosphate cement was considered histologically superior. Calcium phosphate cement was a reliable subchondral replacement material when the bone defect is adjacent to the articular cartilage.
authors.affiliation: Department of Orthopedic Surgery, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan. tome@hiroshima-u.ac.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Hisatome
authors.forename: Yuji
authors.initials: Y
authors.lastname: Yasunaga
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Ikuta
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Fujimoto
mesh_terms: D000818:Animals; D001696:Biomechanical Phenomena; D001843:Bone Cements / Q000494:pharmacology* / Q000592:standards; D018786:Bone Substitutes / Q000009:adverse effects / Q000737:chemistry / Q000592:standards*; D002130:Calcium Phosphates; D002358:Cartilage, Articular / Q000187:drug effects* / Q000473:pathology; D005269:Femur; D008297:Male; D023421:Models, Animal; D010012:Osteogenesis / Q000187:drug effects; D019904:Polymethyl Methacrylate; D011817:Rabbits
chemical_list: D001843:Bone Cements; D018786:Bone Substitutes; D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; D019904:Polymethyl Methacrylate; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous